Beta Bionics, Inc. (BBNX) on GreekSoup https://greeksoup.ai/stocks/us/bbnx/ Every dated entry in the public record on Beta Bionics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Beta Bionics, Inc.: Mensinger Mike (Chief Product Officer) sold 2,650 shares (under a trading plan set in advance) at $22.00 on 27 October 2026, $58,300https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-10-29:73fb06f448Thu, 29 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Hopman Mark (Chief Commercial Officer) sold 821 shares (under a trading plan set in advance) at $20.00 on 26 October 2026, $16,420https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-10-28:e88bfdbd14Wed, 28 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc. Q3 FY2026 results: revenue $36 million, net income -$24 millionhttps://greeksoup.ai/stocks/us/bbnx/results/fy2026-q3/us:BBNX:result:2026-10-27:bc56fe2922Tue, 27 Oct 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/bbnx/filings/us:BBNX:filing:2026-10-27:77df2c554cTue, 27 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/bbnx/filings/us:BBNX:filing:2026-10-27:9dc498bdc5Tue, 27 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Hopman Mark (Chief Commercial Officer) sold 775 shares at $17.35 on 14 October 2026, $13,446https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-10-16:e1f8638eccFri, 16 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: short interest 6,917,021 shares at the 15 October 2026 settlement, 7.38 days to coverhttps://greeksoup.ai/stocks/us/bbnx/short-interest/us:BBNX:short-interest:2026-10-15:0263ee6aa1Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Schedule 13G filed by T. Rowe Price Associates, Inc., 16.6% of the classhttps://greeksoup.ai/stocks/us/bbnx/holders/us:BBNX:schedule-13:2026-10-07:ae39c1389fWed, 07 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Hopman Mark (Chief Commercial Officer) sold 370 shares at $18.96 on 1 October 2026, $7,015https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-10-05:72e385008dMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, MARK HOPMAN plans to sell 2,660 shares worth $50,487 around 1 October 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-10-01:f54dc9b1f4Thu, 01 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: short interest 6,046,389 shares at the 30 September 2026 settlement, 3.25 days to coverhttps://greeksoup.ai/stocks/us/bbnx/short-interest/us:BBNX:short-interest:2026-09-30:eb380b449fWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Jones Christy (Director) sold 6,430 shares (under a trading plan set in advance) at $23.00 on 22 September 2026, $147,890https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-23:27157aef5fWed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, CHRISTINA JONES plans to sell 8,942 shares worth $197,082 around 22 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-22:c3a8544286Tue, 22 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/bbnx/filings/us:BBNX:filing:2026-09-17:91eb663f09Thu, 17 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Hopman Mark (Chief Commercial Officer) sold 30,779 shares (under a trading plan set in advance) at $20.13 on 16 September 2026, $619,640https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-17:ca98c876d8Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Mensinger Mike (Chief Product Officer) sold 2,650 shares (under a trading plan set in advance) at $22.00 on 16 September 2026, $58,300https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-17:ebe8aa93d1Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, MICHAEL MENSINGER plans to sell 5,300 shares worth $101,919 around 16 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-16:c415b899d9Wed, 16 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, MARK HOPMAN plans to sell 28,119 shares worth $540,728 around 16 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-16:3fa80b984aWed, 16 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/bbnx/filings/us:BBNX:filing:2026-09-15:fce8c98118Tue, 15 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Hopman Mark (Chief Commercial Officer) sold 775 shares (under a trading plan set in advance) at $15.52 on 14 September 2026, $12,028https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-15:f5d94ddf07Tue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: short interest 10,617,768 shares at the 15 September 2026 settlement, 9.91 days to coverhttps://greeksoup.ai/stocks/us/bbnx/short-interest/us:BBNX:short-interest:2026-09-15:68087c204cTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Hopman Mark (Chief Commercial Officer) sold 36,870 shares (under a trading plan set in advance) at $18.46 on 9 September 2026, $680,723https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-10:bbd928cbebThu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, MARK HOPMAN plans to sell 40,305 shares worth $779,096 around 9 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-09:6e28fe6941Wed, 09 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Saint Sean (President & CEO) sold 5,641 shares (under a trading plan set in advance) at $20.08 on 3 September 2026, $113,259https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-04:d9c2694380Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, Steven Jon Russell plans to sell 4,221 shares worth $81,951 around 2 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-03:5ee0adfce5Thu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, Michael R. Mensinger plans to sell 4,375 shares worth $84,941 around 2 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-03:042f28eac7Thu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, Mark Hopman plans to sell 5,327 shares worth $103,424 around 2 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-03:cbc2e2ba25Thu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, Sean Saint plans to sell 5,641 shares worth $113,259 around 3 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-03:12ea21b9f7Thu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, Stephen Feider plans to sell 6,675 shares worth $129,595 around 2 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-03:62324c2c32Thu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Form 144, Sean Saint plans to sell 16,867 shares worth $327,473 around 2 September 2026https://greeksoup.ai/stocks/us/bbnx/planned-sales/us:BBNX:planned-sale:2026-09-03:fd1d19a942Thu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Hopman Mark (Chief Commercial Officer) sold 5,327 shares at $19.11 on 2 September 2026, $101,815https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-03:d3ea93d562Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Russell Steven Jon (Chief Medical Officer) sold 4,221 shares at $19.11 on 2 September 2026, $80,676https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-03:5c0105167fThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Mensinger Mike (Chief Product Officer) sold 4,375 shares at $19.11 on 2 September 2026, $83,620https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-03:84dc33d249Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Feider Stephen (Chief Financial Officer) sold 6,675 shares at $19.11 on 2 September 2026, $127,580https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-03:5a99ffa62bThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Saint Sean (President & CEO) sold 16,867 shares at $19.11 on 2 September 2026, $322,381https://greeksoup.ai/stocks/us/bbnx/insiders/us:BBNX:insider:2026-09-03:60e9af5d38Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: short interest 9,400,691 shares at the 31 August 2026 settlement, 9.01 days to coverhttps://greeksoup.ai/stocks/us/bbnx/short-interest/us:BBNX:short-interest:2026-08-31:eacc405da3Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: short interest 7,494,706 shares at the 14 August 2026 settlement, 5.47 days to coverhttps://greeksoup.ai/stocks/us/bbnx/short-interest/us:BBNX:short-interest:2026-08-14:8ea7336e35Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beta Bionics, Inc.: Schedule 13G/A filed by Farallon Capital Management, L.L.C., 1.3% of the classhttps://greeksoup.ai/stocks/us/bbnx/holders/us:BBNX:schedule-13:2026-08-13:57eaf33915Thu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]>